The long-standing standard of care for patients with carotid artery disease was surgery and/or medical management. In August 2004, the U.S. Food and Drug Administration changed all that when it approved the first carotid stenting system, called the RX ACCULINK Carotid Artery Stent System and RX ACCUNET Embolic Protection System by Guidant.
